Based on our findings that DARPP-32 promotes lung cancer survival and migration, combined with previous studies implicating DARPP-32 as an oncogenic factor contributing to breast cancer and gastric tumor progression12,46, we sought to determine whether DARPP-32 drives lung cancer growth in vivo. Here, PPP1R1B is linked to lung carcinoma.